Mi az ára Adamis Pharmaceuticals Corporation (ADMP)

Adamis Pharmaceuticals Corporation (ADMP) ára $0.6241

Mi a Adamis Pharmaceuticals Corporation (ADMP piaci tőkésítése)

Adamis Pharmaceuticals Corporation piaci tőkésítése (ADMP) $836.88K

Adamis Pharmaceuticals Corporation (ADMP) Ár és Piaci Kapitalizáció

Adamis Pharmaceuticals Corporation is a specialized biopharmaceutical company primarily engaged in the development and commercialization of products within the United States, targeting key therapeutic domains such as allergy, opioid overdose, respiratory conditions, and inflammatory diseases. Its current product portfolio includes SYMJEPI pre-filled epinephrine syringes for the emergency treatment of severe allergic reactions, including anaphylaxis; dry powder inhaler products designed for asthma management; and injectable naloxone for addressing opioid overdose. Additionally, Adamis is advancing pipeline candidates such as APC400, a tempol gel aimed at mitigating radiation-induced dermatitis in cancer patients, and APC410, formulated to treat a range of respiratory ailments including asthma, respiratory syncytial virus (RSV), influenza, and COVID-19. The company also extends its offerings to include corticosteroids, hormone replacement therapies, hospital outsourcing products, and other injectables, alongside a line of veterinary pharmaceutical products. Established in 2006, Adamis Pharmaceuticals Corporation maintains its headquarters in San Diego, California.

A ADMP ára	B aktíva	A B piaci tőkésítése	Eredmények
$4,069,160 $836.88K	NVDA	$5.457T	+652,004,306.55%
$3,342,907 $836.88K	AAPL	$4.483T	+535,636,340.23%
$3,100,445 $836.88K	GOOG	$4.158T	+496,786,537.53%
$2,745,690 $836.88K	MSFT	$3.682T	+439,943,749.52%
$2,111,042 $836.88K	AMZN	$2.831T	+338,253,677.87%

A ADMP ára

B aktíva

A B piaci tőkésítése

Eredmények

$4,069,160 $836.88K